Literature DB >> 17368617

Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala.

Lawrence P Reagan1, Robert M Hendry, Leah R Reznikov, Gerardo G Piroli, Gwendolyn E Wood, Bruce S McEwen, Claudia A Grillo.   

Abstract

Chronic restraint stress affects hippocampal and amygdalar synaptic plasticity as determined by electrophysiological, morphological and behavioral measures, changes that are inhibited by some but not all antidepressants. The efficacy of some classes of antidepressants is proposed to involve increased phosphorylation of cAMP response element binding protein (CREB), leading to increased expression of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF). Conversely, some studies suggest that acute and chronic stress downregulate BDNF expression and activity. Accordingly, the aim of the current study was to examine total and phosphorylated CREB (pCREB), as well as BDNF mRNA and protein levels in the hippocampus and amygdala of rats subjected to chronic restraint stress in the presence and absence of the antidepressant tianeptine. In the hippocampus, chronic restraint stress increased pCREB levels without affecting BDNF mRNA or protein expression. Tianeptine administration had no effect upon these measures in the hippocampus. In the amygdala, BDNF mRNA expression was not modulated in chronic restraint stress rats given saline in spite of increased pCREB levels. Conversely, BDNF mRNA levels were increased in the amygdala of chronic restraint stress/tianeptine rats in the absence of changes in pCREB levels when compared to non-stressed controls. Amygdalar BDNF protein increased while pCREB levels decreased in tianeptine-treated rats irrespective of stress conditions. Collectively, these results demonstrate that tianeptine concomitantly decreases pCREB while increasing BDNF expression in the rat amygdala, increases in neurotrophic factor expression that may participate in the enhancement of amygdalar synaptic plasticity mediated by tianeptine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368617     DOI: 10.1016/j.ejphar.2007.02.023

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  26 in total

Review 1.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

2.  The same antidepressant elicits contrasting patterns of synaptic changes in the amygdala vs hippocampus.

Authors:  Anup Gopalakrishna Pillai; Shobha Anilkumar; Sumantra Chattarji
Journal:  Neuropsychopharmacology       Date:  2012-07-25       Impact factor: 7.853

3.  Treatment with tianeptine induces antidepressive-like effects and alters the neurotrophin levels, mitochondrial respiratory chain and cycle Krebs enzymes in the brain of maternally deprived adult rats.

Authors:  Franciela P Della; Helena M Abelaira; Gislaine Z Réus; Maria Augusta B dos Santos; Débora B Tomaz; Altamir R Antunes; Giselli Scaini; Meline O S Morais; Emilio L Streck; João Quevedo
Journal:  Metab Brain Dis       Date:  2013-01-18       Impact factor: 3.584

4.  Not all stress is equal: CREB is not necessary for restraint stress reinstatement of cocaine-conditioned reward.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Behav Brain Res       Date:  2013-03-01       Impact factor: 3.332

Review 5.  The As and Ds of stress: metabolic, morphological and behavioral consequences.

Authors:  Lawrence P Reagan; Claudia A Grillo; Gerado G Piroli
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

6.  Cannabinoids and Glucocorticoids in the Basolateral Amygdala Modulate Hippocampal-Accumbens Plasticity After Stress.

Authors:  Amir Segev; Irit Akirav
Journal:  Neuropsychopharmacology       Date:  2015-08-20       Impact factor: 7.853

7.  Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons.

Authors:  A M Magariños; C J Li; J Gal Toth; K G Bath; D Jing; F S Lee; B S McEwen
Journal:  Hippocampus       Date:  2011-03       Impact factor: 3.899

Review 8.  Neurobiological and clinical effects of the antidepressant tianeptine.

Authors:  Siegfried Kasper; Bruce S McEwen
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Tianeptine: an antidepressant with memory-protective properties.

Authors:  Phillip R Zoladz; Collin R Park; Carmen Muñoz; Monika Fleshner; David M Diamond
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

Review 10.  The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation.

Authors:  B S McEwen; S Chattarji; D M Diamond; T M Jay; L P Reagan; P Svenningsson; E Fuchs
Journal:  Mol Psychiatry       Date:  2009-08-25       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.